FreeCME
LoginRegister Logout My Profile My Courses

Reducing the Risk of MACE in T2DM with GLP-1RAs: Real World Considerations to Personalize Therapy

CME: 0.75

January 28, 2021
No Comments
/ Print / Reprints /
| Share More
/ Text Size+
Larger Smaller
[X]
Source: https://www.freecme.com/ACHL/diabetesseries

Post a comment to this article